AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Learn about the credit cards that offer the highest cash back rates. Make informed choices to maximize your rewards and savings.
25,960 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Floating-rate Treasuries have provided steadier income as rate volatility persists. This piece examines how USFR deli...
A new permanent-capital firm aims to acquire cash-flowing U.S. businesses from aging founders, paying part in stock a...
When Brookfield Corporation just reported, investors want clarity on cash flow, debt, and capital allocation. This gu...
A clear, investor-focused guide to the IMSR 2025 Earnings Transcript. Learn what the numbers mean for the company’s p...
Two popular small-cap ETFs, VB and ISCB, offer different advantages. VB shines on costs and liquidity, while ISCB may...
KB Home's Q1 2026 results shed light on the company’s earnings trajectory and the housing market dynamics. This guide...
AI hype meets real-world finance. This article explains why I remain cautious on CoreWeave stock, with clear risks, n...
Investors eye the Q4 2025 earnings transcript from Up Fintech (TIGR) to gauge growth, margins, and execution. This gu...
In the race to dominate AI-powered cloud services, Iren's ability rapidly scale data centers sets it apart. This arti...
When a company’s top legal officer discloses a stock sale, investors pay attention. This guide explains how to read i...
As markets wobble over a broader utility pullback, a regulated water utility stands out for steady payouts and depend...